Ulipristal

Overview

Ulipristal is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103846).

API suppliers (2)

Suppliers of Ulipristal backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CURIA SPAIN SAUSpain1 active DMF
• Gedeon RichterHungary

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Ulipristal expires 12 Jun 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

Canonical SMILES

CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O

InChIKey

HKDLNTKNLJPAIY-WKWWZUSTSA-N